15496152

Source:http://linkedlifedata.com/resource/pubmed/id/15496152

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035096, umls-concept:C0205263, umls-concept:C0235989, umls-concept:C0332206, umls-concept:C1136014
pubmed:issue	5
pubmed:dateCreated	2004-10-21
pubmed:abstractText	Experimental aristolochic acid nephropathy (AAN), characterized by interstitial fibrosis, tubular atrophy, and chronic renal failure, was reported after 35-day injections of aristolochic acids (AA) to salt-depleted male Wistar rats. The link between renal fibrosis and the renin-angiotensin system (RAS) in this model remains unknown.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0323470
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Aristolochic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Enalapril, http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/candesartan
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0085-2538
pubmed:author	pubmed-author:De PrezEric GEG, pubmed-author:DebelleFrédéric DFD, pubmed-author:Deschodt-LanckmanMonique MMM, pubmed-author:HussonCécile PCP, pubmed-author:NortierJoëlle LJL, pubmed-author:RombautKatjaK, pubmed-author:SalmonIsabelle JIJ, pubmed-author:VanherweghemJean-LouisJL, pubmed-author:VienneAnne RAR
pubmed:issnType	Print
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1815-25
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15496152-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:15496152-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15496152-Animals, pubmed-meshheading:15496152-Aristolochic Acids, pubmed-meshheading:15496152-Benzimidazoles, pubmed-meshheading:15496152-Blood Pressure, pubmed-meshheading:15496152-Diet, Sodium-Restricted, pubmed-meshheading:15496152-Drug Synergism, pubmed-meshheading:15496152-Enalapril, pubmed-meshheading:15496152-Fibrosis, pubmed-meshheading:15496152-Kidney, pubmed-meshheading:15496152-Kidney Diseases, pubmed-meshheading:15496152-Male, pubmed-meshheading:15496152-Peptidyl-Dipeptidase A, pubmed-meshheading:15496152-Rats, pubmed-meshheading:15496152-Rats, Wistar, pubmed-meshheading:15496152-Renin-Angiotensin System, pubmed-meshheading:15496152-Tetrazoles
pubmed:year	2004
pubmed:articleTitle	The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids.
pubmed:affiliation	Laboratory for Research on Peptide Metabolism, Faculty of Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. fdebelle@ulb.ac.be
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't